Risk and tropism of central nervous system (CNS) metastases in patients with stage II and III cutaneous melanoma.

Patients with stage IIC melanoma are at elevated risk for first recurrence in the CNS. Surveillance strategies that incorporate serial neuroimaging should be considered for these individuals until more accurate predictive markers can be identified.